Sfoglia per AUTORE
CELIUS EG
Collezione AOU San Luigi di Orbassano

  

Items : 3

Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies. in Neurology and therapy / Neurol Ther. 2020 Dec;9(2):443-457. doi: 10.1007/s40120-020-00191-7. Epub 2020 May 14.

2020
AOU San Luigi di Orbassano

Singer BA; Ziemssen T; Mitsikostas DD; Miller T; Kornek B; Izquierdo G; Hunter SF; Honeycutt WD; Comi G; Havrdova EK; Celius EG; Arroyo R; Bertolotto A; Chung L; Daizadeh N; Afsar S; Hashemi L; Senior P;

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings. in Frontiers in neurology / Front Neurol. 2019 Mar 22;10:253. doi: 10.3389/fneur.2019.00253. eCollection 2019.

2019
AOU San Luigi di Orbassano

Oreja-Guevara C; Meuth SG; Limmroth V; Lee JM; Habek M; Cruz DD; de Seze J; Celius EG; Boster A; Bertolotto A; LaGanke C; Bass AD; Traboulsee A; Carruthers R; Barclay K; Pagnotta P; Vos C; Ziemssen T; Baker DP; Wijmeersch BV;

Association of genetic markers with the presence of cerebrospinal fluid oligoclonal bands in the Italian population in Multiple Sclerosis

2012
AOU San Luigi di Orbassano

Barrizzone N; Leone MA; Esposito F; Lucenti A; Harbo HF; Goris A; Kockum I; Oturai AB; Celius EG; Mero IL; Dubois B; Olsson T; Søndergaard HB; Cusi D; Lupoli S; Guerini F; Galimberti D; Salvetti M; Liberatore G; Naldi P; Myhr K-M; Bergamaschi R; Comi G; Martinelli Boneschi F; D'Alfonso S; Marnetto F; Caldano M; Sala A; Malucchi S; et alii...